Login
Evidence Feed
About
Conferences
New
Diagnostics
New
Top genes
New
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
CANCER:
Gastrointestinal Stromal Tumor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(103)
News
Twitter
Trials
Reset Filters
VERI cancer hierarchy
x
x
x
x
KIT exon 17 mutation
Gastrointestinal Stromal Tumor
KIT exon 17 mutation
Gastrointestinal Stromal Tumor
ripretinib
Sensitive: B - Late Trials
ASCO-GI 2023 - 2 weeks (New C3)
ripretinib
Sensitive
:
B
ASCO-GI 2023 - 2wk
ripretinib
Sensitive: B - Late Trials
ASCO-GI 2023 - 2 weeks
ripretinib
Sensitive
:
B
ASCO-GI 2023 - 2 weeks - (New C3)
KIT exon 11 mutation
Gastrointestinal Stromal Tumor
KIT exon 11 mutation
Gastrointestinal Stromal Tumor
ripretinib
Sensitive: B - Late Trials
ASCO-GI 2023 - 2 weeks (New C3)
ripretinib
Sensitive
:
B
ASCO-GI 2023 - 2wk
ripretinib
Sensitive: B - Late Trials
ASCO-GI 2023 - 2 weeks
ripretinib
Sensitive
:
B
ASCO-GI 2023 - 2 weeks - (New C3)
KIT exon 18 mutation
Gastrointestinal Stromal Tumor
KIT exon 18 mutation
Gastrointestinal Stromal Tumor
ripretinib
Sensitive: B - Late Trials
ASCO-GI 2023 - 2 weeks (New C3)
ripretinib
Sensitive
:
B
ASCO-GI 2023 - 2wk
ripretinib
Sensitive: B - Late Trials
ASCO-GI 2023 - 2 weeks
ripretinib
Sensitive
:
B
ASCO-GI 2023 - 2 weeks - (New C3)
KIT positive
Gastrointestinal Stromal Tumor
KIT positive
Gastrointestinal Stromal Tumor
imatinib
Sensitive: A1 - Approval
imatinib
Sensitive
:
A1
imatinib
Sensitive: A1 - Approval
imatinib
Sensitive
:
A1
PDGFRA D842V
Gastrointestinal Stromal Tumor
PDGFRA D842V
Gastrointestinal Stromal Tumor
avapritinib
Sensitive: A1 - Approval
avapritinib
Sensitive
:
A1
avapritinib
Sensitive: A1 - Approval
avapritinib
Sensitive
:
A1
No biomarker
Gastrointestinal Stromal Tumor
No biomarker
Gastrointestinal Stromal Tumor
sunitinib
Sensitive: A1 - Approval
sunitinib
Sensitive
:
A1
sunitinib
Sensitive: A1 - Approval
sunitinib
Sensitive
:
A1
No biomarker
Gastrointestinal Stromal Tumor
No biomarker
Gastrointestinal Stromal Tumor
ripretinib
Sensitive: A1 - Approval
ripretinib
Sensitive
:
A1
ripretinib
Sensitive: A1 - Approval
ripretinib
Sensitive
:
A1
PDGFRA exon 18 mutation
Gastrointestinal Stromal Tumor
PDGFRA exon 18 mutation
Gastrointestinal Stromal Tumor
avapritinib
Sensitive: A1 - Approval
avapritinib
Sensitive
:
A1
avapritinib
Sensitive: A1 - Approval
avapritinib
Sensitive
:
A1
No biomarker
Gastrointestinal Stromal Tumor
No biomarker
Gastrointestinal Stromal Tumor
regorafenib
Sensitive: A1 - Approval
regorafenib
Sensitive
:
A1
regorafenib
Sensitive: A1 - Approval
regorafenib
Sensitive
:
A1
KIT expression
Gastrointestinal Stromal Tumor
KIT expression
Gastrointestinal Stromal Tumor
imatinib
Sensitive: A1 - Approval
imatinib
Sensitive
:
C1
imatinib
Sensitive: A1 - Approval
imatinib
Sensitive
:
C1
NTRK2 fusion
Gastrointestinal Stromal Tumor
NTRK2 fusion
Gastrointestinal Stromal Tumor
entrectinib
Sensitive: A2 - Guideline
entrectinib
Sensitive
:
A2
entrectinib
Sensitive: A2 - Guideline
entrectinib
Sensitive
:
A2
NTRK1 fusion
Gastrointestinal Stromal Tumor
NTRK1 fusion
Gastrointestinal Stromal Tumor
entrectinib
Sensitive: A2 - Guideline
entrectinib
Sensitive
:
A2
entrectinib
Sensitive: A2 - Guideline
entrectinib
Sensitive
:
A2
NTRK3 fusion
Gastrointestinal Stromal Tumor
NTRK3 fusion
Gastrointestinal Stromal Tumor
entrectinib
Sensitive: A2 - Guideline
entrectinib
Sensitive
:
A2
entrectinib
Sensitive: A2 - Guideline
entrectinib
Sensitive
:
A2
NTRK3 fusion
Gastrointestinal Stromal Tumor
NTRK3 fusion
Gastrointestinal Stromal Tumor
larotrectinib
Sensitive: A2 - Guideline
larotrectinib
Sensitive
:
A2
larotrectinib
Sensitive: A2 - Guideline
larotrectinib
Sensitive
:
A2
NTRK2 fusion
Gastrointestinal Stromal Tumor
NTRK2 fusion
Gastrointestinal Stromal Tumor
larotrectinib
Sensitive: A2 - Guideline
larotrectinib
Sensitive
:
A2
larotrectinib
Sensitive: A2 - Guideline
larotrectinib
Sensitive
:
A2
NTRK1 fusion
Gastrointestinal Stromal Tumor
NTRK1 fusion
Gastrointestinal Stromal Tumor
larotrectinib
Sensitive: A2 - Guideline
larotrectinib
Sensitive
:
A2
larotrectinib
Sensitive: A2 - Guideline
larotrectinib
Sensitive
:
A2
No biomarker
Gastrointestinal Stromal Tumor
No biomarker
Gastrointestinal Stromal Tumor
cabozantinib tablet
Sensitive: A2 - Guideline
cabozantinib tablet
Sensitive
:
A2
cabozantinib tablet
Sensitive: A2 - Guideline
cabozantinib tablet
Sensitive
:
A2
PDGFRA exon 18 mutation
Gastrointestinal Stromal Tumor
PDGFRA exon 18 mutation
Gastrointestinal Stromal Tumor
imatinib
Sensitive: A2 - Guideline
imatinib
Sensitive
:
A2
imatinib
Sensitive: A2 - Guideline
imatinib
Sensitive
:
A2
No biomarker
Gastrointestinal Stromal Tumor
No biomarker
Gastrointestinal Stromal Tumor
imatinib
Sensitive: A2 - Guideline
imatinib
Sensitive
:
A2
imatinib
Sensitive: A2 - Guideline
imatinib
Sensitive
:
A2
PDGFRA D842V
Gastrointestinal Stromal Tumor
PDGFRA D842V
Gastrointestinal Stromal Tumor
dasatinib
Sensitive: A2 - Guideline
dasatinib
Sensitive
:
A2
dasatinib
Sensitive: A2 - Guideline
dasatinib
Sensitive
:
A2
No biomarker
Gastrointestinal Stromal Tumor
No biomarker
Gastrointestinal Stromal Tumor
sorafenib
Sensitive: A2 - Guideline
sorafenib
Sensitive
:
A2
sorafenib
Sensitive: A2 - Guideline
sorafenib
Sensitive
:
A2
No biomarker
Gastrointestinal Stromal Tumor
No biomarker
Gastrointestinal Stromal Tumor
pazopanib
Sensitive: A2 - Guideline
pazopanib
Sensitive
:
A2
pazopanib
Sensitive: A2 - Guideline
pazopanib
Sensitive
:
A2
No biomarker
Gastrointestinal Stromal Tumor
No biomarker
Gastrointestinal Stromal Tumor
nilotinib
Sensitive: A2 - Guideline
nilotinib
Sensitive
:
A2
nilotinib
Sensitive: A2 - Guideline
nilotinib
Sensitive
:
A2
KIT mutation
Gastrointestinal Stromal Tumor
KIT mutation
Gastrointestinal Stromal Tumor
ripretinib
Sensitive: B - Late Trials
ripretinib
Sensitive
:
B
ripretinib
Sensitive: B - Late Trials
ripretinib
Sensitive
:
B
PDGFRA mutation
Gastrointestinal Stromal Tumor
PDGFRA mutation
Gastrointestinal Stromal Tumor
ripretinib
Sensitive: B - Late Trials
ripretinib
Sensitive
:
B
ripretinib
Sensitive: B - Late Trials
ripretinib
Sensitive
:
B
KIT exon 9 mutation
Gastrointestinal Stromal Tumor
KIT exon 9 mutation
Gastrointestinal Stromal Tumor
regorafenib
Sensitive: B - Late Trials
regorafenib
Sensitive
:
B
regorafenib
Sensitive: B - Late Trials
regorafenib
Sensitive
:
B
KIT mutation
Gastrointestinal Stromal Tumor
KIT mutation
Gastrointestinal Stromal Tumor
pimitespib
Sensitive: B - Late Trials
pimitespib
Sensitive
:
B
pimitespib
Sensitive: B - Late Trials
pimitespib
Sensitive
:
B
KIT exon 13 mutation
Gastrointestinal Stromal Tumor
KIT exon 13 mutation
Gastrointestinal Stromal Tumor
ripretinib
Sensitive: B - Late Trials
ripretinib
Sensitive
:
B
ripretinib
Sensitive: B - Late Trials
ripretinib
Sensitive
:
B
KIT exon 9 mutation
Gastrointestinal Stromal Tumor
KIT exon 9 mutation
Gastrointestinal Stromal Tumor
ripretinib
Sensitive: B - Late Trials
ripretinib
Sensitive
:
B
ripretinib
Sensitive: B - Late Trials
ripretinib
Sensitive
:
B
KIT exon 17 mutation
Gastrointestinal Stromal Tumor
KIT exon 17 mutation
Gastrointestinal Stromal Tumor
regorafenib
Sensitive: B - Late Trials
regorafenib
Sensitive
:
B
regorafenib
Sensitive: B - Late Trials
regorafenib
Sensitive
:
B
KIT exon 13 mutation
Gastrointestinal Stromal Tumor
KIT exon 13 mutation
Gastrointestinal Stromal Tumor
regorafenib
Sensitive: B - Late Trials
regorafenib
Sensitive
:
B
regorafenib
Sensitive: B - Late Trials
regorafenib
Sensitive
:
B
KIT exon 11 mutation
Gastrointestinal Stromal Tumor
KIT exon 11 mutation
Gastrointestinal Stromal Tumor
regorafenib
Sensitive: B - Late Trials
regorafenib
Sensitive
:
B
regorafenib
Sensitive: B - Late Trials
regorafenib
Sensitive
:
B
KIT exon 18 mutation
Gastrointestinal Stromal Tumor
KIT exon 18 mutation
Gastrointestinal Stromal Tumor
regorafenib
Sensitive: B - Late Trials
regorafenib
Sensitive
:
B
regorafenib
Sensitive: B - Late Trials
regorafenib
Sensitive
:
B
KIT exon 14 mutation
Gastrointestinal Stromal Tumor
KIT exon 14 mutation
Gastrointestinal Stromal Tumor
regorafenib
Sensitive: B - Late Trials
regorafenib
Sensitive
:
B
regorafenib
Sensitive: B - Late Trials
regorafenib
Sensitive
:
B
PDGFRA mutation
Gastrointestinal Stromal Tumor
PDGFRA mutation
Gastrointestinal Stromal Tumor
avapritinib
Sensitive: C2 – Inclusion Criteria
avapritinib
Sensitive
:
C2
avapritinib
Sensitive: C2 – Inclusion Criteria
avapritinib
Sensitive
:
C2
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login